Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-04

Clinical Trial Update: DCRT vs. Surgery in Resectable ESCC Patient Achiving cCR/PR After nCI [Phase 2]

View source ↗

Summary

Phase 2 trial comparing definitive chemoradiation therapy versus surgery in patients with resectable esophageal squamous cell carcinoma who achieve complete or …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Esophageal Cancer | Phase 2 | Status: RECRUITING